Valuation: Boule Diagnostics AB

Market Cap 142M 14.57M 12.76M 11.78M 11M 20.71M 1.38B 21.18M 54.72M 680M 54.72M 53.52M 2.36B P/E 2026 *
-14.5x
P/E 2027 * 16.5x
Enterprise Value 338M 34.78M 30.45M 28.11M 26.25M 49.42M 3.29B 50.54M 131M 1.62B 131M 128M 5.63B EV / Sales 2026 *
0.75x
EV / Sales 2027 * 0.68x
Free-Float
50.4%
Yield 2026 *
-
Yield 2027 * -
1 day+3.70%
1 week+9.25%
Current month+13.86%
1 month+15.95%
3 months-4.79%
6 months-23.01%
Current year-23.01%
1 week 3.21
Extreme 3.21
3.94
1 month 3.09
Extreme 3.09
3.94
Current year 3.09
Extreme 3.09
5.68
1 year 3.09
Extreme 3.09
10.6
3 years 3.09
Extreme 3.09
12.62
5 years 3.09
Extreme 3.09
61.9
10 years 3.09
Extreme 3.09
108.88
Manager TitleAgeSince
Chief Executive Officer - 2026-06-21
Director of Finance/CFO 54 2026-02-10
Chief Executive Officer - 2024-04-15
Director TitleAgeSince
Director/Board Member 59 2013-12-31
Chairman 73 2020-12-31
Chairman 74 2022-12-31
Date Insider Type Main position Quantity % Market Cap.
23-02-26Buy

Chief Financial Officer

8,000 0.0206%
23-02-05Buy

Director

7,083 0.0182%
22-02-16Buy

Director

2,000 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
+3.56%+9.25%-56.65%-65.19% 14.57M
-1.29%+9.14%+24.04%-1.55% 188B
+0.31%+0.75%-23.93%+19.94% 144B
-1.74%+8.19%-3.03%-18.92% 136B
-1.70%-1.92%-59.19%-18.41% 64.63B
+0.44%+6.17%+16.58%-0.91% 52.5B
+1.07%-0.49%-27.01%-33.76% 43.4B
-2.34%+5.01%+11.46%+12.52% 37.52B
-1.48%+2.96%+4.67%+40.82% 36.22B
-1.08%+7.27%-12.54%-17.32% 29.59B
Average +0.80%+4.85%-12.56%-8.28% 73.23B
Weighted average by Cap. +0.42%+5.68%-4.41%-1.74%

Financials

2026 *2027 *
Net sales 453M 46.58M 40.79M 37.65M 35.16M 66.19M 4.4B 67.7M 175M 2.17B 175M 171M 7.54B 483M 49.69M 43.51M 40.16M 37.51M 70.6M 4.7B 72.21M 187M 2.32B 187M 183M 8.05B
Net income -9.77M -1M -880K -812K -758K -1.43M -94.99M -1.46M -3.77M -46.86M -3.77M -3.69M -163M 8.6M 884K 774K 714K 667K 1.26M 83.55M 1.28M 3.32M 41.22M 3.32M 3.25M 143M
Net Debt 197M 20.21M 17.69M 16.33M 15.25M 28.71M 1.91B 29.36M 75.88M 942M 75.88M 74.21M 3.27B 185M 18.97M 16.61M 15.33M 14.32M 26.95M 1.79B 27.57M 71.23M 885M 71.24M 69.67M 3.07B
Logo Boule Diagnostics AB
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company’s product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company’s primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
Employees
200
Date Price Change Volume
26-06-30 SEK 3.780 +3.56% 32,457
26-06-29 SEK 3.650 +1.67% 7,318
26-06-26 SEK 3.590 0.00% 3,103
26-06-25 SEK 3.590 +8.13% 32,884
26-06-24 SEK 3.320 -4.05% 29,624
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3.650SEK
Average target price
3.800SEK
Spread / Average Target
+4.11%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BOUL Stock